Clinical Trial: A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pulmonary Hypertension (World Health Organization Group 2)
Study Type: INTERVENTIONAL
Official Title: A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group
Brief Summary:
This study is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart failure (HF) and pulmonary hypertension (PH) Group 2
Read more